• Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665–3670

  PubMed CAS  Google Scholar 

• Correa CR, Calixto JB (1993) Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110:193–198

  Article PubMed CAS  Google Scholar 

• Damas J, Liegeois JF (1999) The inflammatory reaction induced by formalin in the rat paw. Naunyn-Schmeidebergs Arch Pharmacol 359:220–227

  Article CAS  Google Scholar 

• Dixon WJ (1965) The up-and-down method for small samples. J Am Stat Assoc 60:967–978

  Article  Google Scholar 

• Ellis A, Benson N, Machin I, Corradini L (2008). The rat formalin test: Can it predict neuropathic pain? In: Spink AJ, Ballintjin MR, Bogers ND, Grieco F, Loijens LWS, Noldus LPJJ, Smit G, Zimmerman PH (eds) Proceedings of measuring behavior, Maastricht, The Netherlands, August 26–29, pp 324–325

• Fine PG (2004) Opioid insights: opioid-induced hyperalgesia and opioid rotation. J Pain Palliatcare Pharmacother 18:75–79

  Google Scholar 

• Gardocki JF, Yelnosky J (1964) A study of some of the pharmacological actions of fentanyl citrate. Toxicol Appl Pharmacol 6:48–62

  Article PubMed CAS  Google Scholar 

• Hallenbeck JL (2003) Palliative care perspective. Oxford University Press, Inc., New York

  Book  Google Scholar 

• Helsley GC, Lunsford CD, Welstead WJ Jr, Boswell RF, Funderburk WH, Johnson DN (1969) Synthesis and analgetic activity of some 1-substituted 3-pyrrolidinylanilides and dihydrobenzoxazinones. J Med Chem 12:583–586

  Google Scholar 

• Higashikawa Y, Suzuki S (2008) Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure–analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 26:1–5

  Article CAS  Google Scholar 

• Hug CC, Murphy MR (1981) Tissue redistribution of fentanyl and termination of its effects in rats. Anaesthesiology 55:369–375

  Article CAS  Google Scholar 

• Hunskar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103–114

  Article  Google Scholar 

• Irwin S (1964) Drug screening and evaluation of new compounds in animals. In: Nodin JH, Siegler PE (eds) Animal and clinical techniques in drug evaluation. Year Book Medical Publishers, Chicago, pp 36–54

  Google Scholar 

• Irwin S (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia (Berl) 13:222–257

  Article CAS  Google Scholar 

• Ivanović MD, Vučkovic S, Ristović Z, Mićović IV, Beleslin DB (1995) Behavioral effects of fentanyl in rats. Iugav Physiol Pharmacol Acta 31:195–199

  Google Scholar 

• Janssen PAJ (1965) 1-Aralkyl-4-(N-aryl carbonylamino)piperidines and related compounds. US Patent 3, 164 600

• Johnson M (2009) MSDS on fentanyl citrate. Macfarlan Smith Limited, Edinburgh

• Leavitt SB (2009) Opioid antagonists, naloxone & naltrexene-Aids for pain management. An overview of clinical evidence. Pain Treatment Topics, Glenview, IL, 60025.http://Pain-Topics.Org, 1–16

• Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharm Exp Ther 96:99–113

  CAS  Google Scholar 

• Mather LE (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8:422–446

  Article PubMed CAS  Google Scholar 

• Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, Lipkowski J, Dybala I, Koziol AE (2002) Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines. Eur J Med Chem 37:761–772

  Article PubMed CAS  Google Scholar 

• McGinty J, Friedman D (1988) Opioids in the hippocampus. Natl Inst Drug Abuse Res Monogr Ser 82:1–145

  CAS  Google Scholar 

• McNicol E, Boyce D, Schumann R, Carr D (2008) Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev. CD006332. PMID 18425947

• Mićović IV, Ivanović MD, Vuckovic SM, Prostran MŠ, Došen-Mićović L, Kiricojević VD (2000) The synthesis and preliminary pharmacological evaluation of 4-methyl fentanyl. Biorg Med Chem Letts 10:2011–2014

  Article  Google Scholar 

• Perlikowska R, Fichna J, Claude de-Rego J, Gach K, Janecka A (2011) Kinetic studies of novel inhibitors of endomorphine degrading enzymes. Med Chem Res. doi:10.1007/s00044-011-9666-5

• Qi H, Li W, Qiu Y, Cui Y, Ma J, Gao X, Zeng Y, Yang J, Tang Y, Wang X, Sheng W, Xie Q, Liu J, Qiu Z, Chen H (2011) Synthesis and evaluation of k-opioid receptor agonistic activity and antinociceptive effect of novel morphine analogues, 7α-phenyl-6α, 14α-endo-etheno-tetrahydrothebaine with substitutedo-,m- andp-amino group. Med Chem Res 20:1364–1370. doi:10.1007/s00044-010-9471-6

  Article CAS  Google Scholar 

• Shibata M, Ohkubo T, Takashi H, Inoki R (1989) Modified formalin test. Pain 38:345–352

  Article  Google Scholar 

• Van Bever WFM, Niemegeers CJE, Janssen PAJ (1974) Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers ofN-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide andN-[3- methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide. J Med Chem 17:1047–1051

  Article PubMed  Google Scholar 

• Van Nimmen NFJ, Poels KLC, Veulemans HAF (2004) Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of pictogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J Chromat B 804:375–387

  Article  Google Scholar 

• Vogel HG (2002) Psychotropic and neurotropic activity. In: Drug discovery and evaluation. Pharmacological assays. Springer, Berlin

• Vučkovic S, Ivanović M, Prostran M, Todorović Z, Ristović Z, Mićović I, Beleslin D (1998) Higher environmental temperature potentiates cataleptic effect of fentanyl. Jpn J Pharmacol 78:523–527

  Article PubMed  Google Scholar 

• Vučkovic S, Prostran M, Ivanović M, Dosen-Mićović L, Vujović KS, Vucetic C, Kadija M, Mićović Z (2011) Pharmacological evaluation of 3-carbomethoxy fentanyl in mice. Pharmaceuticals 4:233–243

  Article  Google Scholar 

Download references